What's on it
Nine lines: therapeutic fit, investigator availability, likely-eligible patients against the target, competing studies, procedures and equipment, startup timeline, budget against cost per patient, coordinator capacity, and history with the sponsor or CRO. There is space for conditions, and a line for the decision, the date and the owner.
